Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women
暂无分享,去创建一个
[1] W. Willett,et al. Use of Postmenopausal Hormones and Risk of Myocardial Infarction , 1981, Circulation.
[2] T. Lind,et al. A PROSPECTIVE, CONTROLLED TRIAL OF SIX FORMS OF HORMONE REPLACEMENT THERAPY GIVEN TO POSTMENOPAUSAL WOMEN , 1979, British journal of obstetrics and gynaecology.
[3] S. Gitel,et al. Do natural estrogens pose an increased risk of thrombosis in postmenopausal women? , 1978, Thrombosis research.
[4] G. Whipple,et al. Coronary risk and estrogen use in postmenopausal women. , 1978, American journal of epidemiology.
[5] J. Davies,et al. THE EFFECTS OF LONG‐TERM THERAPY WITH OESTRIOL UCCINATE ON THE HAEMOSTATIC MECHANISM IN OSTMENOPAUSAL WOMEN , 1978 .
[6] J. Davies,et al. The effects of long-term therapy with oestriol succinate on the haemostatic mechanism in postmenopausal women. , 1978, British journal of obstetrics and gynaecology.
[7] H. Ory,et al. Association between oral contraceptives and myocardial infarction. A review. , 1977, JAMA.
[8] L. Poller,et al. Conjugated equine oestrogens and blood clotting: a follow-up report. , 1977, British medical journal.
[9] G B Phillips,et al. Relationship between serum sex hormones and glucose, insulin and lipid abnormalities in men with myocardial infarction. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[10] H. Jick,et al. Myocardial infarction and estrogen therapy in post-menopausal women. , 1976, The New England journal of medicine.
[11] G. Mcnicol,et al. The Effects of Therapy with Oestriol Succinate and Ethinyl Oestradiol on the Haemostatic Mechanism in Post-Menopausal Women , 1976, Thrombosis and Haemostasis.
[12] M. Notelovitz,et al. Natural estrogen and anti-thrombin III activity in postmenopausal women. , 1976, The Journal of reproductive medicine.
[13] J. Bonnar. Effects of synthetic and natural estrogens on the coagulation system in post-menopausal women , 1976 .
[14] M. Notelovitz,et al. The effect of natural oestrogens on coagulation. , 1975, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[15] R. Scherz. Letter: Childproofing the medicines bottle. , 1974, Lancet.
[16] B. Barnes. The Coronary Drug Project , 1972 .
[17] R Denis,et al. [Survival of patients with cancer of the prostate]. , 1972, Journal d'urologie et de nephrologie.
[18] D. Byar,et al. Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo , 1970, Cancer.
[19] W. Inman,et al. Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs , 1970, British medical journal.
[20] A. Masi,et al. THROMBOEMBOLISM AND ORAL CONTRACEPTIVES: AN EPIDEMIOLOGIC CASE-CONTROL STUDY , 1970 .
[21] A. Masi,et al. Thromboembolism and oral contraceptives: an epidemiologic case-control study. , 1969, American journal of epidemiology.
[22] M. Elder,et al. Plasma factor IX levels in patients given hexoestrol or stilboestrol to suppress lactation , 1969, British medical journal.
[23] R. Doll,et al. Investigation of Relation between Use of Oral Contraceptives and Thromboembolic Disease. A Further Report , 1969, British medical journal.
[24] Clyne,et al. Investigation of relation between use of oral contraceptives and thromboembolic disease. , 1968, British medical journal.
[25] A. Bloom,et al. Increased factor IX levels in puerperium during administration of diethylstilboestrol. , 1968, British medical journal.
[26] J. Starup,et al. The coagulation mechanism in oral contraception. , 1967, Acta obstetricia et gynecologica Scandinavica.
[27] H. Campbell,et al. Puerperal thromboembolism and suppression of lactation. , 1967, Lancet.
[28] S. Kullander,et al. Coagulation And Fibrinolytic Studies During Use Of Gestagens , 1967, Acta obstetricia et gynecologica Scandinavica.
[29] L. Poller,et al. Clotting Factors during Oral Contraception: Further Report , 1966, British medical journal.